The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
I see that ViroLogic now offers information on the replicative capacity of patient virus, alongside information on its genotypic and phenotypic resistance profile. How should we use this information ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines: You have to credit our authors. You ...
A public health emergency is about to emerge because of federal ADAP (AIDS Drug Assistance Program) funding cuts. Long since ...
The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One area that has been particularly hard hit has been research, prevention, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results